688506.SS
688506.SS
CNE100006FN4
SICHUAN BIOKIN PHARMACEUTICAL C
Loading chart...

Company Profile

Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, manufacture, and sale of biomedicine in the fields of antibody drug conjugate, guidance navigation and control, and antibody radionuclide conjugate in China and internationally. It offers anesthesia, parenteral nutrition, anti-infectives, pediatrics, and traditional Chinese medicines. The company was founded in 1996 and is headquartered in Chengdu, China.

Related stocks

000538.SZ
000538.SZ • China
YUNNAN BAIYAO
51.4 CNY
13.72B USD 1Y -10.4%
002001.SZ
002001.SZ • China
NHU
26.58 CNY
12.22B USD 1Y +6.1%
000963.SZ
000963.SZ • China
HD MEDICINE
27.29 CNY
7.16B USD 1Y -34.6%
000999.SZ
000999.SZ • China
CR SANJIU
24.82 CNY
6.18B USD 1Y -12.3%
600196.SS
600196.SS • China
SHANGHAI FOSUN PHARMACEUTICAL G
23.89 CNY
9.55B USD 1Y -19.9%
600085.SS
600085.SS • China
BEIJING TONG REN TANG CO
24.28 CNY
4.98B USD 1Y -29.3%
1276.HK
1276.HK • China
HENGRUI PHARMA
48 HKD
40.6B USD 1Y -45.3%
4507.T
4507.T • Japan
SHIONOGI & CO
2,744.5 JPY
14.76B USD 1Y +8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
64.7% p.a.
Max Drawdown (5Y)
-50.1%
Sharpe Ratio (5Y)
1.02
Beta Factor
-0.05
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (64.7% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -50.1% in the extended horizon.
ende